A typical initial course might involve one 3ml ampoule administered intramuscularly once daily or 2-3 times per week for several weeks, followed by a maintenance dose if necessary, based on individual response and clinical need
Our team is trained to manage potential side effects
So I Googled what I was presented
First 2 weeks: cellular preparation (no visible changes) What's happening (invisible): GHK-Cu binding to receptors Gene expression changes beginning Fibroblast activation Collagen synthesis machinery ramping up Anti-inflammatory processes starting Cellular repair initiating What you won't see yet: No visible skin improvements No wrinkle reduction No firmness increase No texture changes Essentially looks the same Why the lag: Collagen takes weeks to accumulate Skin turnover cycle is 28-40 days Structural changes require time Visible benefits need threshold amount of new collagen What to do during this phase: Continue protocol consistently Don't get discouraged Document with photos (before baseline) Trust the process Most people quit here (mistake!) Dosing during weeks 1-2: Standard protocol: 1-2mg 3-5x weekly Aggressive: 2-3mg daily Don't increase dose out of impatience Consistency matters more than dose Weeks 3-6: first subtle improvements Early visible changes (if looking closely): Slight texture improvement (smoother) Minor firmness increase (skin feels tighter) Possible glow/radiance Hydration improvement Pore size may reduce slightly Still not dramatic: Most people don't notice without comparing photos Friends/family won't comment Need good lighting to see differences Progress is gradual What's actually happening: Collagen accumulation now measurable Skin barrier function improving Hydration retention increasing Fine lines starting to soften (very subtly) Week-by-week expectations: Staying motivated: Take weekly photos (same lighting/angle) Compare to baseline Track subjective skin feel (firmness, smoothness) Don't expect miracles yet See our peptides for anti-aging category and how long do peptides take to work
Among these, late-onset nodules are a concern that can arise weeks, months, or even years after the initial treatment
Regarding DML b (chr17: 34283701), ZNF136 (JASPAR ID: MA1588.1) can bind to the complementary region in the minus strand, but there is no evidence of its action on CCL11 expression
